A detailed history of Ubs Group Ag transactions in Brainsway Ltd. stock. As of the latest transaction made, Ubs Group Ag holds 1,659 shares of BWAY stock, worth $16,307. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,659
Previous 593 179.76%
Holding current value
$16,307
Previous $3,000 400.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.8 - $9.24 $6,182 - $9,849
1,066 Added 179.76%
1,659 $15,000
Q2 2024

Aug 13, 2024

SELL
$4.75 - $7.08 $7,315 - $10,903
-1,540 Reduced 72.2%
593 $3,000
Q1 2024

May 13, 2024

SELL
$5.25 - $7.46 $37,038 - $52,630
-7,055 Reduced 76.78%
2,133 $11,000
Q4 2023

Feb 09, 2024

BUY
$3.16 - $7.07 $29,034 - $64,959
9,188 New
9,188 $59,000
Q3 2022

Nov 10, 2022

SELL
$3.53 - $6.9 $116 - $227
-33 Reduced 9.02%
333 $1,000
Q2 2022

Aug 10, 2022

SELL
$4.5 - $8.96 $2,160 - $4,300
-480 Reduced 56.74%
366 $2,000
Q1 2022

May 16, 2022

BUY
$7.08 - $8.88 $736 - $923
104 Added 14.02%
846 $7,000
Q4 2021

Feb 14, 2022

BUY
$7.09 - $8.7 $5,260 - $6,455
742 New
742 $6,000
Q2 2021

Aug 13, 2021

SELL
$8.25 - $11.62 $8,464 - $11,922
-1,026 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$7.08 - $10.03 $474 - $672
67 Added 6.99%
1,026 $9,000
Q4 2020

Feb 11, 2021

BUY
$5.58 - $7.54 $1,908 - $2,578
342 Added 55.43%
959 $7,000
Q3 2020

Nov 12, 2020

BUY
$5.52 - $8.0 $910 - $1,320
165 Added 36.5%
617 $4,000
Q2 2020

Jul 31, 2020

BUY
$5.89 - $8.55 $300 - $436
51 Added 12.72%
452 $3,000
Q1 2020

May 01, 2020

BUY
$5.23 - $12.31 $162 - $381
31 Added 8.38%
401 $3,000
Q4 2019

Feb 14, 2020

BUY
$8.3 - $10.83 $3,071 - $4,007
370 New
370 $4,000
Q3 2019

Nov 14, 2019

SELL
$8.55 - $10.8 $18,194 - $22,982
-2,128 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$8.66 - $11.5 $18,428 - $24,472
2,128 New
2,128 $22,000

Others Institutions Holding BWAY

About Brainsway Ltd.


  • Ticker BWAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 16,519,200
  • Market Cap $162M
  • Description
  • Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addictio...
More about BWAY
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.